Trial Profile

Regulatory T-cell induction by low-dose interleukin-2 in women with unexplained early spontaneous early miscarriages (FCRI)

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 17 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aldesleukin (Primary)
Indications Spontaneous abortion
Focus Therapeutic Use
Acronyms FACIL-2

Most Recent Events

25 Apr 2024 Status changed from active, no longer recruiting to completed.
21 Mar 2024 Planned End Date changed from 5 Feb 2025 to 5 Apr 2024.
10 Jul 2023 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com